NO305756B1 - 6,7-modifiserte paclitaxeler, anvendelse derav til fremstilling av et preparat til behandling av mammale tumorer, samt et farmas°ytisk preparat inneholdende en av forbindelsene - Google Patents

6,7-modifiserte paclitaxeler, anvendelse derav til fremstilling av et preparat til behandling av mammale tumorer, samt et farmas°ytisk preparat inneholdende en av forbindelsene

Info

Publication number
NO305756B1
NO305756B1 NO934277A NO934277A NO305756B1 NO 305756 B1 NO305756 B1 NO 305756B1 NO 934277 A NO934277 A NO 934277A NO 934277 A NO934277 A NO 934277A NO 305756 B1 NO305756 B1 NO 305756B1
Authority
NO
Norway
Prior art keywords
preparation
alkyl
compounds
formula
treatment
Prior art date
Application number
NO934277A
Other languages
English (en)
Norwegian (no)
Other versions
NO934277D0 (no
NO934277L (no
Inventor
Shu-Hui Chen
Vittorio Farina
Gregory Roth
John Kadow
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/128,619 external-priority patent/US5380751A/en
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO934277D0 publication Critical patent/NO934277D0/no
Publication of NO934277L publication Critical patent/NO934277L/no
Publication of NO305756B1 publication Critical patent/NO305756B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO934277A 1992-12-04 1993-11-26 6,7-modifiserte paclitaxeler, anvendelse derav til fremstilling av et preparat til behandling av mammale tumorer, samt et farmas°ytisk preparat inneholdende en av forbindelsene NO305756B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98576192A 1992-12-04 1992-12-04
US08/128,619 US5380751A (en) 1992-12-04 1993-09-28 6,7-modified paclitaxels

Publications (3)

Publication Number Publication Date
NO934277D0 NO934277D0 (no) 1993-11-26
NO934277L NO934277L (no) 1994-06-06
NO305756B1 true NO305756B1 (no) 1999-07-19

Family

ID=26826766

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934277A NO305756B1 (no) 1992-12-04 1993-11-26 6,7-modifiserte paclitaxeler, anvendelse derav til fremstilling av et preparat til behandling av mammale tumorer, samt et farmas°ytisk preparat inneholdende en av forbindelsene

Country Status (20)

Country Link
EP (1) EP0600517B1 (zh)
JP (1) JP3360186B2 (zh)
CN (1) CN1049433C (zh)
AT (1) ATE195939T1 (zh)
AU (1) AU668777B2 (zh)
CA (1) CA2109861C (zh)
CZ (1) CZ287599B6 (zh)
DE (1) DE69329327T2 (zh)
DK (1) DK0600517T3 (zh)
ES (1) ES2149188T3 (zh)
FI (1) FI109795B (zh)
GR (1) GR3034686T3 (zh)
HU (2) HU222347B1 (zh)
IL (1) IL107819A (zh)
MX (1) MX9307555A (zh)
NO (1) NO305756B1 (zh)
NZ (1) NZ250343A (zh)
PL (1) PL178135B1 (zh)
PT (1) PT600517E (zh)
SG (1) SG55014A1 (zh)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998656A (en) 1991-09-23 1999-12-07 Florida State University C10 tricyclic taxanes
IL107950A (en) 1992-12-15 2001-04-30 Upjohn Co b 7, b 8 - Matano - Taxols, their preparation and pharmaceutical preparations against malignant tumors containing them
IL108316A (en) * 1993-01-15 2006-10-31 Univ Florida State History of C-10 Texan and pharmaceuticals containing them
ES2219968T3 (es) * 1993-06-11 2004-12-01 PHARMACIA & UPJOHN COMPANY Uso antineoplasico de delta 6,7-taxoles y composiciones farmaceuticas que los contienen.
IL127597A (en) * 1994-01-28 2003-07-31 Upjohn Co Iso-taxol analogs
US5395850A (en) * 1994-03-10 1995-03-07 Bristol-Myers Squibb Company 6,7-epoxy paclitaxels
GB9409131D0 (en) * 1994-05-09 1994-06-29 Erba Carlo Spa Unsaturated taxane compounds
FR2721026B1 (fr) * 1994-06-09 1996-07-12 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2721025B1 (fr) * 1994-06-09 1996-07-12 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5840929A (en) * 1995-04-14 1998-11-24 Bristol-Myers Squibb Company C4 methoxy ether derivatives of paclitaxel
FR2742753B1 (fr) * 1995-12-22 1998-01-30 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
US5773461A (en) * 1996-06-06 1998-06-30 Bristol-Myers Squibb Company 7-deoxy-6-substituted paclitaxels
US5635531A (en) * 1996-07-08 1997-06-03 Bristol-Myers Squibb Company 3'-aminocarbonyloxy paclitaxels
US5773464A (en) * 1996-09-30 1998-06-30 Bristol-Myers Squibb Company C-10 epoxy taxanes
US5977386A (en) * 1996-12-24 1999-11-02 Bristol-Myers Squibb Company 6-thio-substituted paclitaxels
US5902822A (en) * 1997-02-28 1999-05-11 Bristol-Myers Squibb Company 7-methylthiooxomethyl and 7-methylthiodioxomethyl paclitaxels
US5912264A (en) * 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
US6017935A (en) * 1997-04-24 2000-01-25 Bristol-Myers Squibb Company 7-sulfur substituted paclitaxels
IT1317731B1 (it) * 2000-01-18 2003-07-15 Indena Spa Tassani semisintetici con attivita' antitumorale ed antiangiogenetica.
US6649632B2 (en) 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
PL350331A1 (en) 2000-02-02 2002-12-02 Univ Florida State Res Found C10 carbamoyloxy substituted taxanes as antitumor agents
RU2264400C2 (ru) 2000-02-02 2005-11-20 Флорида Стейт Юниверсити Рисерч Фаундейшн, Инк. Таксан, фармацевтическая композиция на его основе и способ ингибирования роста опухоли
CN1362956A (zh) 2000-02-02 2002-08-07 佛罗里达州立大学研究基金有限公司 C7氨基甲酰氧基取代的紫衫烷抗肿瘤剂
KR100607612B1 (ko) 2001-06-20 2006-08-02 제넨테크, 인크. 종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물
EP2153843B1 (en) 2001-09-18 2012-08-15 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US20030228305A1 (en) 2002-01-02 2003-12-11 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
EP1571968A4 (en) 2002-04-16 2007-10-17 Genentech Inc COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TUMORS
JP2005528905A (ja) 2002-06-07 2005-09-29 ジェネンテック・インコーポレーテッド 腫瘍の診断と治療のための組成物と方法
SI2161283T1 (sl) 2003-11-17 2014-10-30 Genentech, Inc. Sestavki, ki obsegajo protitelesa proti CD79b, konjugirana na sredstvo, ki inhibira rast, ali na citotoksično sredstvo, in postopki za zdravljenje tumorja hematopoetskega izvora
PE20050693A1 (es) * 2004-02-13 2005-09-27 Univ Florida State Res Found Taxanos sustituidos con esteres de ciclopentilo en c10
GT200500025A (es) * 2004-02-13 2005-09-30 Taxanos sustituidos con esteres de ciclopentilo en c10
EP2230517A1 (en) 2005-01-07 2010-09-22 Diadexus, Inc. OVR110 antibody compositions and methods of use
EP2614839A3 (en) 2006-04-05 2015-01-28 Genentech, Inc. Method for using BOC/CDO to modulate hedgehog signaling
WO2008067283A2 (en) 2006-11-27 2008-06-05 Diadexus, Inc. Ovr110 antibody compositions and methods of use
WO2008103962A2 (en) 2007-02-22 2008-08-28 Genentech, Inc. Methods for detecting inflammatory bowel disease
CN111499748A (zh) 2007-07-16 2020-08-07 健泰科生物技术公司 抗cd79b抗体和免疫偶联物及使用方法
PE20090481A1 (es) 2007-07-16 2009-05-18 Genentech Inc Anticuerpos anti-cd79b e inmunoconjugados humanizados y metodos de uso
EP3269737B1 (en) 2008-01-31 2024-06-19 Genentech, Inc. Anti-cd79b antibodies and immunoconjugates and methods of use
WO2009145981A1 (en) 2008-03-31 2009-12-03 Florida State University Research Foundation, Inc. C(10) ethyl ester and c(10) cyclopropyl ester substituted taxanes
JP6132548B2 (ja) 2009-04-01 2017-05-24 ジェネンテック, インコーポレイテッド 抗FcRH5抗体および免疫接合体および使用方法
CN102711826B (zh) 2009-10-22 2017-03-29 霍夫曼-拉罗奇有限公司 用于调控巨噬细胞刺激性蛋白的hepsin活化的方法和组合物
PE20121584A1 (es) 2009-11-30 2012-11-29 Genentech Inc Composiciones y metodos para el diagnostico y el tratamiento de tumores
AR080243A1 (es) 2010-02-23 2012-03-21 Genentech Inc Composiciones y metodos para el diagnostico y tratamiento de tumores
MA34291B1 (fr) 2010-05-03 2013-06-01 Genentech Inc Compositions et méthodes de diagnostic et de traitement d'une tumeur
CN104650012A (zh) * 2013-11-22 2015-05-27 天士力控股集团有限公司 一种紫杉烷类化合物
WO2015116902A1 (en) 2014-01-31 2015-08-06 Genentech, Inc. G-protein coupled receptors in hedgehog signaling
KR20210003147A (ko) 2018-04-13 2021-01-11 제넨테크, 인크. 안정된 항-cd79b 면역접합체 제제

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US4876399A (en) * 1987-11-02 1989-10-24 Research Corporation Technologies, Inc. Taxols, their preparation and intermediates thereof
US5175315A (en) * 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
US5015744A (en) * 1989-11-14 1991-05-14 Florida State University Method for preparation of taxol using an oxazinone
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
US5227400A (en) * 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
US5272171A (en) * 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
ES2219968T3 (es) * 1993-06-11 2004-12-01 PHARMACIA & UPJOHN COMPANY Uso antineoplasico de delta 6,7-taxoles y composiciones farmaceuticas que los contienen.

Also Published As

Publication number Publication date
FI109795B (fi) 2002-10-15
JP3360186B2 (ja) 2002-12-24
MX9307555A (es) 1995-01-31
CZ260393A3 (en) 1994-07-13
SG55014A1 (en) 1998-12-21
DK0600517T3 (da) 2000-10-30
PL301305A1 (en) 1994-06-13
PL178135B1 (pl) 2000-03-31
PT600517E (pt) 2000-12-29
IL107819A (en) 2000-06-29
HU222347B1 (hu) 2003-06-28
AU668777B2 (en) 1996-05-16
NZ250343A (zh) 1996-11-26
CA2109861C (en) 1999-03-16
EP0600517A1 (en) 1994-06-08
HU221817B1 (hu) 2003-01-28
AU5212193A (en) 1994-06-16
CN1094041A (zh) 1994-10-26
GR3034686T3 (en) 2001-01-31
CA2109861A1 (en) 1994-06-05
HUT65640A (en) 1994-07-28
HU9303428D0 (en) 1994-04-28
EP0600517B1 (en) 2000-08-30
DE69329327D1 (de) 2000-10-05
JPH06211823A (ja) 1994-08-02
NO934277D0 (no) 1993-11-26
FI935381A (fi) 1994-06-05
ES2149188T3 (es) 2000-11-01
NO934277L (no) 1994-06-06
CN1049433C (zh) 2000-02-16
CZ287599B6 (en) 2001-01-17
DE69329327T2 (de) 2001-04-05
IL107819A0 (en) 1994-04-12
ATE195939T1 (de) 2000-09-15
FI935381A0 (fi) 1993-12-01

Similar Documents

Publication Publication Date Title
NO305756B1 (no) 6,7-modifiserte paclitaxeler, anvendelse derav til fremstilling av et preparat til behandling av mammale tumorer, samt et farmas°ytisk preparat inneholdende en av forbindelsene
IL129059A0 (en) Taxol derivatives and processes for their preparation
HU9301902D0 (en) Fluorinic derivatives of taxole, method for producing them and anti-cancer preparatives containing said compounds as active agent